BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24275260)

  • 1. Community-acquired infections and their association with myeloid malignancies.
    Titmarsh GJ; McMullin MF; McShane CM; Clarke M; Engels EA; Anderson LA
    Cancer Epidemiol; 2014 Feb; 38(1):56-61. PubMed ID: 24275260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
    Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
    J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of myeloid malignancies in patients with autoimmune conditions.
    Anderson LA; Pfeiffer RM; Landgren O; Gadalla S; Berndt SI; Engels EA
    Br J Cancer; 2009 Mar; 100(5):822-8. PubMed ID: 19259097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens.
    Mundt KA; Dell LD; Boffetta P; Beckett EM; Lynch HN; Desai VJ; Lin CK; Thompson WJ
    BMC Cancer; 2021 Mar; 21(1):227. PubMed ID: 33676443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
    Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
    Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia.
    Anderson LA; Landgren O; Engels EA
    Br J Haematol; 2009 Nov; 147(4):444-9. PubMed ID: 19725826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Activity, Sitting Time, and Risk of Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Other Myeloid Malignancies.
    Rees-Punia E; Patel AV; Fallon EA; Gapstur SM; Teras LR
    Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1489-1494. PubMed ID: 31196856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
    Kaplan HG; Malmgren JA; Atwood MK
    BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
    Kaplan HG; Malmgren JA; Li CI; Calip GS
    Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
    Kaplan H; Malmgren J; De Roos AJ
    Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study.
    McShane CM; Murray LJ; Engels EA; Landgren O; Anderson LA
    Int J Cancer; 2014 Apr; 134(7):1734-40. PubMed ID: 24105662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 16. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis.
    Teras LR; Patel AV; Carter BD; Rees-Punia E; McCullough ML; Gapstur SM
    Br J Haematol; 2019 Jul; 186(2):243-254. PubMed ID: 30977126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
    Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
    Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
    Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
    Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.